Key Statistics for 4541
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4541
- Net Income (M/JPY)
Nichi-iko Pharmaceutical Co., Ltd. manufactures and sells prescription drugs. The Company developed measuring application for patients to prevent from any respiratory fits such as asthma. Nichiiko Pharmaceutical also offers information on medical drugs and supplies through internet.
More Company Profile & Key Executives for 4541
|Yuichi TamuraPresident||Toshinori KongohjiSenior Managing Exec Officer|
|Shuko UrayamaSenior Managing Exec Officer||Kenji AkaneSenior Managing Exec Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries